182 related articles for article (PubMed ID: 23484777)
1. Voriconazole induced bradycardia.
Uludağ D; Ozdemir N; Tüysüz G; Eroğlu AG; Celkan T
Pediatr Hematol Oncol; 2013 Oct; 30(7):674-6. PubMed ID: 23484777
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole-associated severe hyponatremia.
Kim KH; Lee S; Lee S; Yun NR; Kim NJ; Yu KS; Jang IJ; Park WB; Oh MD
Med Mycol; 2012 Jan; 50(1):103-5. PubMed ID: 21671829
[TBL] [Abstract][Full Text] [Related]
3. Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation.
Chow E; Moore T; Nielsen K
Pediatr Infect Dis J; 2003 Dec; 22(12):1109-10. PubMed ID: 14688580
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
Cesaro S; Strugo L; Alaggio R; Cecchetto G; Rigobello L; Pillon M; Cusinato R; Zanesco L
Support Care Cancer; 2003 Nov; 11(11):722-7. PubMed ID: 13680324
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
Walsh TJ; Lutsar I; Driscoll T; Dupont B; Roden M; Ghahramani P; Hodges M; Groll AH; Perfect JR
Pediatr Infect Dis J; 2002 Mar; 21(3):240-8. PubMed ID: 12005089
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
Okamoto T; Koh K; Takita J; Furuya A; Kato M; Ida K
Pediatr Int; 2010 Feb; 52(1):137-41. PubMed ID: 20158658
[No Abstract] [Full Text] [Related]
7. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole therapy in children with cystic fibrosis.
Hilliard T; Edwards S; Buchdahl R; Francis J; Rosenthal M; Balfour-Lynn I; Bush A; Davies J
J Cyst Fibros; 2005 Dec; 4(4):215-20. PubMed ID: 16243008
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole-associated myositis.
Shanmugam VK; Matsumoto C; Pien E; Rosen J; Kumar P; Whelton S; Steen V
J Clin Rheumatol; 2009 Oct; 15(7):350-3. PubMed ID: 20009971
[TBL] [Abstract][Full Text] [Related]
11. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of pulmonary aspergillosis. Role of voriconazole (discussion)].
Kohno S; Ogawa K; Kurashima A; Niki Y; Maesaki S
Jpn J Antibiot; 2007 Dec; 60(6):321-34. PubMed ID: 18447204
[No Abstract] [Full Text] [Related]
13. Voriconazole-induced retinoid-like photosensitivity in children.
Rubenstein M; Levy ML; Metry D
Pediatr Dermatol; 2004; 21(6):675-8. PubMed ID: 15575856
[TBL] [Abstract][Full Text] [Related]
14. Pseudoporphyria as a result of voriconazole use: a case report.
Dolan CK; Hall MA; Blazes DL; Norwood CW
Int J Dermatol; 2004 Oct; 43(10):768-71. PubMed ID: 15485539
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
Howard A; Hoffman J; Sheth A
Ann Pharmacother; 2008 Dec; 42(12):1859-64. PubMed ID: 19017830
[TBL] [Abstract][Full Text] [Related]
16. Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice.
Heinz WJ; Silling G; Böhme A
Curr Med Res Opin; 2011 Feb; 27(2):335-42. PubMed ID: 21155707
[TBL] [Abstract][Full Text] [Related]
17. Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
Soler-Palacín P; Frick MA; Martín-Nalda A; Lanaspa M; Pou L; Roselló E; de Heredia CD; Figueras C
J Antimicrob Chemother; 2012 Mar; 67(3):700-6. PubMed ID: 22190607
[TBL] [Abstract][Full Text] [Related]
18. Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.
Kim SH; Yim DS; Choi SM; Kwon JC; Han S; Lee DG; Park C; Kwon EY; Park SH; Choi JH; Yoo JH
Int J Infect Dis; 2011 Nov; 15(11):e753-8. PubMed ID: 21831685
[TBL] [Abstract][Full Text] [Related]
19. Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT.
Molina JR; Serrano J; Sánchez-García J; Rodríguez-Villa A; Gómez P; Tallón D; Martín V; Rodríguez G; Rojas R; Martín C; Martínez F; Alvarez MA; Torres A
Bone Marrow Transplant; 2012 Apr; 47(4):562-7. PubMed ID: 21572466
[TBL] [Abstract][Full Text] [Related]
20. Voriconazole-induced pancreatitis in a patient of acute myeloid leukemia and invasive aspergillosis.
Philip A; Sivaprakasam P; Sagar TG; Ganesan P
J Pediatr Hematol Oncol; 2012 Jul; 34(5):406. PubMed ID: 22713708
[No Abstract] [Full Text] [Related]
[Next] [New Search]
